NASDAQ: SNSE
Sensei Biotherapeutics Inc Stock Ownership - Who owns Sensei Biotherapeutics?

Insider buying vs selling

Have Sensei Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John CelebiPRESIDENT AND CEO2025-02-195,558$0.48
$2.65kSell
Der Horst Edward VanCHIEF SCIENTIFIC OFFICER2025-02-192,276$0.48
$1.08kSell

1 of 1

SNSE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SNSE insiders and whales buy or sell their stock.

SNSE Shareholders

What type of owners hold Sensei Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
James Peyer700.99%8,841,457$76.74MInsider
Hs Investments I LP350.91%4,425,998$38.42MInsider
Cambrian Biopharma Inc289.63%3,653,120$31.71MInsider
Thomas G. Ricks54.36%685,632$5.95MInsider
John Celebi8.39%105,862$918.88kInsider
Robert Hamilton Pierce7.49%94,463$819.94kInsider
Erin Colgan5.35%67,462$585.57kInsider
Der Horst Edward Van4.74%59,794$519.01kInsider
Patrick Stephen Gallagher2.71%34,130$296.25kInsider
Vanguard Group Inc2.31%29,090$252.50kInstitution

1 of 3

SNSE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SNSE0.39%99.61%Net Selling
PCSA0.74%8.06%Net Buying
LPTX28.54%71.46%Net Selling
INAB3.61%96.39%Net Buying
BCDA0.16%99.84%Net BuyingNet Buying

Sensei Biotherapeutics Stock Ownership FAQ

Who owns Sensei Biotherapeutics?

Sensei Biotherapeutics (NASDAQ: SNSE) is owned by 5.54% institutional shareholders, 1,431.28% Sensei Biotherapeutics insiders, and 0.00% retail investors. James Peyer is the largest individual Sensei Biotherapeutics shareholder, owning 8.84M shares representing 700.99% of the company. James Peyer's Sensei Biotherapeutics shares are currently valued at $76.74M.

If you're new to stock investing, here's how to buy Sensei Biotherapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.